Pharming Group NV has appointed Kenneth Lynard as chief financial officer effective 1 October as the company builds growth following strong first half 2025 results. Mr Lynard has over 20 years’ experience in the life sciences industry, most recently as CFO of Schoeller Allibert and Zentiva, a European pharmaceutical company. He was previously senior vice president and CFO at Gilead Sciences Inc. He holds a master of science in business economics and auditing from Copenhagen Business School, Denmark, and an executive MBA from the Institute for Management Development in Lausanne, Switzerland.
Copyright 2025 Evernow Publishing Ltd